# Breast Pumps Market

> Breast Pump Market Research Report By Technology (Manual Pumps, Battery Powered Pumps and Electric Pumps), By Product (Open System and Closed System), By Application (Personal Use and Hospital Grade), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Industry Forecast Till 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 9.1%
- **2025:** USD 3.87 Billion
- **2035:** USD 9.22 Billion
- **Key Players:** Medela AG, Koninklijke Philips N.V., Pigeon Corporation, Spectra Baby, Lansinoh Laboratories, Momcozy, Chiaro Technology (Elvie), Willow Innovations

**Report ID:** MRFR/HC/10760-HCR · **Pages:** 133 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** September 10, 2026

**URL:** https://www.marketresearchfuture.com/reports/breast-pumps-market-12281

---

## Market Summary

The Global Breast Pump Market size was valued at USD 3.082 Billion in 2024, and the market is projected to grow from USD 3.356 Billion in 2025 to USD 7.874 Billion by 2035, registering a CAGR of 8% during the forecast period 2025–2035. North America led the market in 2024 with over 40% share, generating around USD 1.23 Billion in revenue.
 
Rising awareness about breastfeeding benefits and increasing participation of women in the workforce are major growth drivers for the global market. Supportive healthcare policies, improved maternal care access, and technological advancements in portable electric pumps are further accelerating adoption globally among modern mothers. 
 
According to the World Health Organization (WHO), exclusive breastfeeding for the first six months could prevent nearly 820,000 child deaths annually worldwide. Growing global awareness regarding breastfeeding benefits is significantly increasing demand for convenient and efficient breast pump solutions among working mothers and healthcare providers.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Workplace lactation mandates | 2.1 | North America, Europe | Short-term (≤2 yr) | [1][2] |
| Hands-free wearable innovation | 1.8 | Global | Medium-term (2–4 yr) | [3] |
| Insurance and public reimbursement | 1.5 | North America | Short-term (≤2 yr) | [5] |
| E-commerce and D2C channel shift | 1.3 | Global | Medium-term (2–4 yr) | [11] |
| Rising female labour participation | 1.1 | Asia-Pacific | Long-term (≥4 yr) | [12] |
| NICU and donor-milk infrastructure | 0.8 | Global | Long-term (≥4 yr) | [8] |
| Maternal-health public funding | 0.6 | Asia-Pacific, MEA | Long-term (≥4 yr) | [13] |

### Statutory Lactation Accommodation

Enforcement, not legislation, moved the needle. The PUMP Act's private-right-of-action provisions took effect in April 2023, and the U.S. Department of Labor logged a measurable rise in nursing-mother complaint resolutions the following year [[1]](https://dol.gov/agencies/whd/pump-at-work). Employers with more than 50 staff now budget for multi-user closed-system stations rather than reimbursing personal purchases, lifting average institutional order values above USD 1,900 per lactation room.

### Reimbursement Architecture

Coverage mechanics shape unit economics. Under the Affordable Care Act preventive-services requirement, most U.S. plans cover one pump per pregnancy with no cost sharing, and durable-medical-equipment suppliers report that roughly four in five personal-use units now clear through insurance rather than cash retail [[5]](https://cms.gov). That guaranteed floor lets manufacturers invest in premium tiers priced above the reimbursement allowance.

### Digital Health Integration

Connectivity converted a commodity appliance into a monitored care device. Manufacturer studies submitted alongside FDA 510(k) clearances report expression-time reductions near 18% when adaptive suction profiles replace fixed cycling [[14]](https://accessdata.fda.gov). Clinicians increasingly treat pump telemetry as a supply-adequacy signal, and several U.S. health systems now fold that data into postpartum follow-up protocols.

### Asia-Pacific Policy Push

The region's governments linked postpartum assistance to fertility incentives. While South Korea's birth-encouragement package finances municipal nursing rooms, China's province appropriations for maternal and child health topped RMB 12 billion in 2024, some of which subsidize hospital lactation equipment [[7]](https://nhc.gov.cn)[[13]](https://mohw.go.kr). In both markets, demand roughly tracks the subsidy line.

## Restraints

## Restraints Impact Analysis

Restraint weightings reflect estimated drag on adoption velocity within the Breast Pumps Market. Values are directional and should not be subtracted from the forecast CAGR.

| Restraint | ~% Drag on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Declining birth cohorts | 1.4 | East Asia, Europe | Long-term (≥4 yr) | [6] |
| Regulatory approval cost and delay | 0.9 | Europe | Medium-term (2–4 yr) | [9] |
| Price compression from low-cost entrants | 0.8 | Asia-Pacific | Short-term (≤2 yr) | [11] |
| Low awareness in emerging economies | 0.7 | MEA, South America | Long-term (≥4 yr) | [15] |
| Hygiene and recall liability | 0.4 | Global | Medium-term (2–4 yr) | [14] |

### Demographic Headwinds

Fewer births mean fewer first-time buyers. Japan recorded under 730,000 annual births in 2024, and South Korea's total fertility rate sat near 0.75, compressing the natural replacement base in two of the region's highest-ASP markets [[6]](https://oecd.org/els/family/database). Manufacturers offset this through longer accessory attach cycles and rental conversion rather than unit growth.

### Regulatory Friction in Europe

Budgets intended for launches were diverted by recertification. Portfolio rationalization was driven by EU Medical Device Regulation transition timelines, and mid-sized suppliers estimated conformity-assessment costs ranging from EUR 180,000 to EUR 350,000 per device family [[9]](https://health.ec.europa.eu). Rather than recertifying them, a number of legacy open-system SKUs were discontinued.

### Margin Pressure from Value Entrants

Cross-border marketplaces changed the price ceiling. Direct-import wearable units frequently list 40–55% below established brand equivalents, and independent teardown testing has flagged inconsistent vacuum calibration in a share of those devices [[11]](https://unctad.org). Brand owners now defend margin through clinical validation and warranty depth rather than feature count.

## Opportunities

## Breast Pumps Market Opportunities

### Rental and Subscription Economics

Hospitals already rent; households are next. Converting a USD 350 one-time purchase into a USD 28 monthly programme bundling flanges, valves and replacement kits raises lifetime value roughly 2.4× across a typical 14-month lactation span, and it locks in consumable revenue that retail cannot capture.

### Clinical-Grade Home Devices

The boundary between ward and bedroom is dissolving. Compact multi-user units that meet closed-system hygiene standards let payers discharge NICU families earlier, and hospital-grade breast pumps positioned for home rental now command premium reimbursement codes in several U.S. states.

### Emerging-Market Penetration

Together, India, Indonesia, Brazil, and Nigeria account for less than 6% of device revenue but a significant portion of the world's births each year. Volume that the premium tier is structurally unable to attain could be unlocked by tiered pricing below USD 60 and localized manufacture under India's Production Linked Incentive plan [[10]](https://mohfw.gov.in).

### Lactation Data Monetisation

Session telemetry has downstream buyers. Anonymised output curves, aggregated across cohorts, support payer risk models, formula-substitution research and postpartum-depression screening pilots — provided consent frameworks satisfy HIPAA and GDPR standards.

### Employer Wellness Channel

Platforms for corporate incentives are an underutilized marketing strategy. By combining gadgets into family-benefit packages, retail discounting is completely avoided, and suppliers with reliable compliance paperwork receive predictable multi-year contracts.

## Future Outlook

## Breast Pumps Market Future Outlook

### Adaptive Intelligence

Suction will personalise. Devices already adjust cycle speed to detected letdown; the next step is longitudinal profiling that flags supply decline before a parent notices, a capability three manufacturers have signalled in regulatory filings [[14]](https://accessdata.fda.gov). Clinical validation, not silicon, is the constraint.

### Platform Economics

Hardware margins compress while ecosystems expand. Suppliers that own the app, the consumable subscription and the payer-billing rail capture materially more lifetime value than those selling boxes, mirroring the trajectory of continuous glucose monitoring.

### Circularity and Materials

Sustainability moves from marketing to procurement scoring. Hospital tenders in the Nordics and Netherlands now weight recyclable componentry and take-back schemes, and the OECD estimates healthcare plastics reduction targets will touch device categories previously exempt [[18]](https://oecd.org).

### Rebalancing Demand Geography

Growth migrates south and east. By 2035 the Breast Pumps Market outside North America and Europe should exceed 40% of global revenue, a shift driven less by policy than by urbanisation and formal-sector employment among women of childbearing age [[12]](https://ilo.org).

## Segment Insights

## Breast Pumps Market Segmentation

### By Product

Product architecture determines who can share a device, which is why closed systems dominate Breast Pumps Market institutional purchasing.

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Closed System Breast Pump | 64.7% share | Multi-user hygiene compliance |
| Open System Breast Pump | USD 1.37 Billion | Entry-level single-user affordability |

Barrier-protected motor housings prevent milk backflow, making closed systems the only architecture hospitals and employers will deploy across multiple users. Open systems survive in cash-retail and gifting channels where single ownership is assumed and price sensitivity is high, but their share erodes roughly 60 basis points annually.

### By Technology

Technology choice within the Breast Pumps Market increasingly reflects mobility rather than suction power.

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Electric Breast Pump | 56.5% share (2025) | Consistent vacuum for frequent expression |
| Battery Powered Breast Pump | 10.1% CAGR (2026–2035) | Cordless use during commute and work |
| Manual Breast Pump | USD 0.66 Billion (2025) | Backup and travel redundancy |

Mains-powered electric units retain clinical preference because vacuum stability is verifiable under load. Battery-powered designs grow faster because they solve a behavioural problem: expression must happen wherever the working day places the parent. Manual pumps have stopped shrinking, functioning now as a deliberate second device rather than a primary purchase.

### By Application

Application mix in the Breast Pumps Market splits cleanly between household ownership and institutional deployment.

| Segment | Metric | Primary Demand Driver |
| --- | --- | --- |
| Personal/ Home Use | USD 2.85 Billion (2025) | Reimbursed individual entitlement |
| Hospital Grade | 11.0% CAGR (2026–2035) | NICU throughput and milk banking |

Home use supplies the volume; institutional use supplies the growth. NICU admission rates around 8–9% of live births in developed systems sustain rental fleets that cycle far harder than consumer units, generating replacement demand on three-to-four-year schedules [[8]](https://rblh.fiocruz.br).

### By Distribution Channel

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Online | 51.5% share | Integrated insurance-billing checkout |
| Offline/ Retail | USD 1.88 Billion | Pharmacy counselling and immediate need |

Online channels command the volume; offline retail supplies the immediacy. An online share of 51.5%, driven by integrated insurance-billing checkout, sustains digital platforms that scale far wider than physical stores, generating steady transaction velocity on automated infrastructure.

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Metric (2025) | Primary Investment Themes |
| --- | --- | --- |
| North America | 37.6% share | Reimbursement-linked D2C, employer lactation programmes |
| Europe | USD 1.06 Billion | MDR-compliant refresh, public hospital tenders |
| Asia-Pacific | 10.5% CAGR | Local manufacturing, e-commerce scale |
| South America | USD 0.22 Billion | Public maternal health, retail pharmacy expansion |
| Middle East & Africa | 4.5% share | Private hospital buildout, donor-milk programmes |
| Total | USD 3.87 Billion | — |

Regional performance in the Breast Pumps Market tracks three variables: reimbursement depth, female workforce participation, and hospital procurement maturity.

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| US | 86.2% of region | Insurance-covered device entitlement [5] |
| Canada | USD 0.13 Billion | Provincial hospital procurement |
| Mexico | 9.4% CAGR | IMSS maternal programme expansion |

Reimbursement makes the U.S. unusually resilient. Durable-medical-equipment suppliers bill roughly 2.4 million pumps annually through insurance channels, and the PUMP Act pushed employers into parallel institutional purchasing [[1]](https://dol.gov/agencies/whd/pump-at-work)[[5]](https://cms.gov). Canada's demand concentrates in tender-driven hospital fleets, while Mexico grows off a small base as public clinics add lactation stations.

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| Germany | 23.1% of region | Statutory health insurance rental schemes |
| UK | USD 0.19 Billion | NHS maternity unit standardisation [16] |
| France | 15.7% of region | Pharmacy-led distribution model |
| Italy | 9.8% of region | Regional hospital consortium buying |
| Spain | 8.2% of the region | Private maternity clinic growth |
| Nordic Countries | 9.6% CAGR | High workforce participation among mothers |
| Russia | USD 0.05 Billion | Domestic substitution policy |
| Rest of Europe | 7.9% of region | Cross-border e-commerce |

Pharmacy remains Europe's gatekeeper. German statutory insurers reimburse rental through pharmacy networks, which sustains multi-user closed-system demand that retail channels rarely touch, and the NHS Better Births framework standardised equipment specifications across English maternity units [[16]](https://england.nhs.uk). MDR compliance costs, meanwhile, thinned the supplier field considerably.

### Asia-Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| China | 41.3% of region | Provincial maternal-health subsidies [7] |
| India | 12.4% CAGR | Institutional delivery rate above 89% [10] |
| Japan | USD 0.14 Billion | Premium device preference |
| South Korea | 8.7% of region | Municipal nursing-room mandates [13] |
| ASEAN | 11.1% CAGR | Urban middle-class formation |
| Rest of Asia-Pacific | 6.3% of region | Marketplace-led access |

Scale and subsidy compound here. China combines domestic manufacturing depth with provincial funding lines, while India's near-universal institutional delivery rate creates a clinical touchpoint at which lactation counselling and device referral can occur [[7]](https://nhc.gov.cn)[[10]](https://mohfw.gov.in). Price ladders run from USD 25 manual units to USD 400 connected wearables within the same city.

### South America

| Country | Metric | Key Driver |
| --- | --- | --- |
| Brazil | 58.4% of region | World's largest human-milk bank network [8] |
| Argentina | USD 0.04 Billion | Private clinic procurement |
| Rest of South America | 9.2% CAGR | Retail pharmacy expansion |

Brazil's Rede Brasileira de Bancos de Leite Humano operates more than 220 milk banks and collection posts, generating steady institutional demand for high-cycle expression equipment and setting a template that Colombia and Peru have begun to replicate [[8]](https://rblh.fiocruz.br). Currency volatility, however, keeps import-dependent premium tiers thinly penetrated.

### Middle East & Africa

| Country | Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 27.6% of region | Vision 2030 hospital investment [17] |
| UAE | USD 0.04 Billion | Private maternity sector density |
| South Africa | 18.3% of region | Public-sector milk banking |
| Egypt | 10.8% CAGR | Population scale, rising urban incomes |
| Rest of MEA | 21.4% of region | Donor and NGO procurement |

Gulf capital projects drive the near-term numbers. Saudi Arabia's health-sector transformation programme funds new maternity capacity, and UAE private hospitals specify branded closed-system equipment as a differentiator [[17]](https://moh.gov.sa). Sub-Saharan demand stays concentrated in donor-funded neonatal programmes rather than consumer retail.

## Competitive Benchmarking

## Competitive Benchmarking

Concentration sits in the medium band. Analyst estimates place the Herfindahl-Hirschman Index near 950–1,100, with the top five suppliers holding an estimated 46–54% of global revenue. Two clinical incumbents anchor the premium tier; a cluster of venture-backed wearable specialists and Asian value manufacturers contests everything below it, producing a competitive structure that is neither oligopoly nor commodity free-for-all.

| Company | Est. Revenue Share Range | Key Offerings for Breast Pumps Market | Strategic Positioning |
| --- | --- | --- | --- |
| Medela AG | ~16–20% | Hospital multi-user systems, double-electric personal units | Clinical gold standard, research-led |
| Koninklijke Philips N.V. | ~12–15% | Avent electric and manual ranges | Global retail distribution scale |
| Pigeon Corporation | ~6–9% | Personal electric and manual pumps | Asia-Pacific brand trust |
| Spectra Baby | ~5–8% | Closed-system rechargeable pumps | Reimbursement-channel specialist |
| Lansinoh Laboratories | ~4–7% | Electric pumps and feeding accessories | Value-premium bridge |
| Momcozy | ~3–6% | Wearable hands-free devices | Digital-native price disruptor |
| Chiaro Technology (Elvie) | ~3–5% | In-bra silent wearables | Design and discretion leadership |
| Willow Innovations | ~3–5% | Spill-proof mobile wearables | Working-parent positioning |
| Ameda Inc. | ~2–4% | Hospital-grade rental fleets | Institutional rental depth |
| Handi-Craft (Dr. Brown's) | ~2–4% | Electric pumps, bottle ecosystem | Feeding-system bundling |
| Ardo Medical AG | ~1–3% | Swiss-engineered clinical pumps | European hospital niche |

## Recent News & Developments

## Recent News & Developments

- Willow Innovations (March 2023): Launched a redesigned in-bra wearable with reduced motor noise, targeting office and travel expression scenarios and expanding the premium mobile tier [[3]](https://.com)
- U.S. Department of Labor (April 2023): PUMP Act remedies provision took full effect, exposing non-compliant employers to private legal action and accelerating institutional procurement [[1]](https://dol.gov/agencies/whd/pump-at-work)
- Medela AG (September 2023): Expanded its Swiss production footprint to shorten European lead times amid MDR-driven portfolio consolidation [[9]](https://health.ec.europa.eu)
- Chiaro Technology (February 2024): Secured additional growth capital to scale U.S. insurance-channel distribution beyond direct retail [[3]](https://.com)
- U.S. EEOC (April 2024): Issued final Pregnant Workers Fairness Act regulations clarifying lactation accommodation obligations for covered employers [[2]](https://eeoc.gov)
- Pigeon Corporation (August 2024): Introduced a rechargeable double-electric line for the China and ASEAN markets at a mid-tier price point [[7]](https://nhc.gov.cn)
- Spectra Baby USA (January 2025): Partnered with a national durable-medical-equipment network to streamline insurance-billed fulfilment [[5]](https://cms.gov)
- Rede Brasileira de Bancos de Leite Humano (May 2025): Announced network expansion targets, increasing institutional demand for high-cycle expression equipment across Brazil [[8]](https://rblh.fiocruz.br)

## Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Global Breast Pumps Market by product, technology, application, distribution channel and geography |
| Study Period | 2021–2035 (Historical 2021–2024; Base Year 2025; Forecast 2026–2035) |
| CAGR | 9.1% (2026–2035) |
| Market Size Checkpoints | USD 3.87 Billion (2025); USD 4.21 Billion (2026); USD 9.22 Billion (2035) |
| Fastest Growing Segments | Battery Powered Breast Pump (technology); Hospital Grade (application); Online (channel) |
| Companies Profiled | 11 major suppliers across clinical, retail, and digital-native tiers |
| Valuation Currency | USD Billion |

## Frequently Asked Questions

**Q: How should a hospital evaluate rental fleet economics before committing capital?**
A: Compare cost-per-expression-hour rather than unit price, since clinical devices cycle far harder than consumer models. Fleets typically break even against outsourced rental at 55–60% utilisation over three years [8].

**Q: What certifications should procurement teams require from Breast Pumps Market suppliers?**
A: Require FDA 510(k) clearance or EU MDR CE marking, ISO 13485 quality certification, and documented closed-system barrier testing. Ask specifically for multi-user validation data, which many consumer-tier suppliers cannot provide [9][14].

**Q: Are wearable devices clinically equivalent to traditional double-electric pumps?**
A: Independent comparisons generally show slightly lower output volume per session from in-bra wearables. Convenience raises session frequency, however, which often offsets the per-session gap over a full day [24].

**Q: How do private-label and OEM arrangements affect Breast Pumps Market competition?**
A: Contract manufacturers in China and South Korea supply several Western brands, compressing technical differentiation. Brand owners consequently compete on app software, clinical evidence, and warranty terms rather than motor hardware [11].

**Q: What are the main integration challenges for connected devices in health systems?**
A: Pump telemetry rarely maps cleanly to existing EHR data standards. Most deployments still rely on parallel vendor dashboards, adding clinician workload rather than reducing it [14].

**Q: Which emerging use cases could expand the Breast Pumps Market beyond postpartum care?**
A: Donor-milk banking and induced-lactation support for adoptive and surrogacy families are both growing. Neither is currently reflected in standard reimbursement categories [8][19].

**Q: What should investors watch as a leading indicator of category momentum?**
A: Track durable-medical-equipment claim volumes and employer benefits-platform attach rates. Both move six to nine months ahead of reported manufacturer revenue [5].


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/breast-pumps-market-12281*